APA aipamena

Celik, H., Wakim, P., Pritchard, W. F., Castro, M., Leonard, S., Karanian, J. W., . . . Wood, B. (2019). RFA Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with RFA Plus Lyso-thermosensitive Liposomal Doxorubicin. J Vasc Interv Radiol.

Chicago Style aipamena

Celik, Haydar, Paul Wakim, William F. Pritchard, Meryll Castro, Shelby Leonard, John W. Karanian, Mark W. Dewhirst, Riccardo Lencioni, and Bradford Wood. "RFA Duration Per Tumor Volume May Correlate With Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated With RFA Plus Lyso-thermosensitive Liposomal Doxorubicin." J Vasc Interv Radiol 2019.

MLA aipamena

Celik, Haydar, et al. "RFA Duration Per Tumor Volume May Correlate With Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated With RFA Plus Lyso-thermosensitive Liposomal Doxorubicin." J Vasc Interv Radiol 2019.